RJ Mackenzie
RJ Mackenzie is a freelance science reporter based in Glasgow, Scotland. He covers biological and biomedical science. He has degrees in neuroscience from the University of Edinburgh and the University of Cambridge. A 2024 FRONTIERS Fellow, RJ has previously written for Nature, National Geographic, and The Scientist.
Articles by RJ Mackenzie
| 4 min read
Trontinemab clears amyloid faster and more safely than previous drugs for Alzheimer’s disease. Will it convince skeptical regulators?
| 3 min read
Largest molecular analysis to date reveals more than 100 blood biomarkers tied to the disease.
| 4 min read
Researchers showed that insulin resistance exists on a spectrum among diabetics and healthy controls.
| 4 min read
Discover how ubrogepant provides migraine relief during the prodrome phase, easing symptoms before headaches fully develop.
| 3 min read
New research shows a promising treatment for chronic back pain by targeting undying cells. Learn how senolytic drugs could revolutionize pain management.
| 3 min read
A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.
| 3 min read
A statistical model using two measures of brain activity could anticipate if people given an injection would be in severe pain for the next month.
| 3 min read
An enzyme reconstructed from a three-billion-year-old bacterium widens gene editing capabilities to even more regions of the genome.
| 3 min read
Injectable micelles that release glucagon could provide a new way to treat hypoglycemic events in diabetes.
| 3 min read
A new vaccination schedule pumps up the immune response to human immunodeficiency virus, overcoming a barrier that has frustrated vaccine designers.
| 4 min read
The therapy met its primary endpoints in two Phase 3 studies and offers a new approach for the tens of millions of people living with the psychiatric condition.
| 3 min read
The new complex is inexpensive to produce, and its unique architecture makes chemical reactions integral to drug discovery more stable and efficient.
